Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

• Status: Terminated
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a trial in obese subjects to study the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of PF-05231023.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Male and female subjects of non-childbearing potential between the ages of 21 and 70.

• Subjects with a BMI of 30 to 45.4 kg/m2 and total body weight >110 lbs.

Exclusion Criteria:

• Recent (6 months) unstable concurrent disease.

• History of allergic disease or drug allergies.

• Any condition affecting food consumption or absorption.